Molina Healthcare, Inc. (MOH) fair value analysis

S&P 500 · Updated 2026-09-07

Molina Healthcare, Inc. is a managed care company that provides health insurance coverage and healthcare services to individuals eligible for government-sponsored programs such as Medicaid and Medicare. The company operates managed care plans across multiple states in the United States, serving low-income families, elderly individuals, and people with disabilities.

Forward Fair Value verdict

Overvalued

Based on TickrTrends' weekly Forward Fair Value model, MOH is trading at more than a 25% premium to estimated fair value.

MOH currently ranks #112 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Overvalued for 3 consecutive weekly runs.

Last price: $200.80
Sector: Healthcare
12-month range: $135.82–$203.06

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: F
Leverage: Moderate
Margin trend: Contracting
Revenue growth: Strong
RSI zone: Neutral
52-week position: The top quarter of its range
DCF cross-check: Overvalued

What our data shows for MOH

Our model validated 17 trailing price-to-earnings windows for MOH, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $135.82–$203.06.
The 14-day relative strength index sits at a neutral 53.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for MOH
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent MOH news

TickrTrends' derived news-sentiment signal for MOH is currently leaning positive, computed from recent coverage.

Molina Healthcare Inc (MOH) -- Strategic Growth in Managed Care | Kopernik Global All Cap Fund Q2 2026 (gurufocus.com, 2026-09-05)
TickrTrends take: MOH's strategic positioning in managed care comes at a time when TickrTrends' valuation analysis indicates the stock is trading above levels supported by current fundamentals. For investors focused on valuation metrics, the company's growth initiatives in managed care will need to demonstrate substantial earnings expansion to justify current pricing relative to peers in the Healthcare sector. The gap between MOH's market valuation and its fundamental value suggests that execution on these growth strategies will be critical in determining whether the overvaluation narrows or persists.
Molina Healthcare (MOH) Surged on Medicaid Clarity and Robust Results (finance.yahoo.com, 2026-08-13)
TickrTrends take: Molina Healthcare operates in the Healthcare sector and currently carries an Overvalued designation from TickrTrends valuation analysis. Recent strength in the stock tied to improved Medicaid visibility and operational performance creates a tension with the current overvaluation assessment, suggesting investors focused on valuation metrics should monitor whether the company's fundamentals can justify current price levels. A valuation-focused reader should track how sustained earnings quality and Medicaid revenue trends develop relative to the stock's existing premium positioning.
Molina Healthcare, Inc. (MOH) Q2 2026 Earnings Call Transcript (seekingalpha.com, 2026-07-24)
TickrTrends take: Molina Healthcare reported Q2 2026 earnings, providing operational metrics that can be assessed against its current market valuation. Given TickrTrends' overvalued rating, investors should examine whether the Q2 results justify the company's current stock price relative to its Healthcare sector peers and fundamental performance metrics. The earnings transcript offers specific financial and operational data points that valuation-focused readers can use to evaluate whether MOH's market pricing reflects realistic expectations for a Healthcare sector company.

What people are saying

Follow the MOH conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is MOH stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), MOH is trading at more than a 25% premium to estimated fair value and screens as overvalued. The exact fair value and discount are available to subscribers.

What is MOH's TickrTrends verdict?

MOH's current verdict is Overvalued, refreshed with every weekly Forward Fair Value run.

How does MOH compare to other Healthcare stocks?

MOH ranks #112 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is MOH overbought or oversold?

MOH's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

MOH vs ACAD · MOH vs ALKS · MOH vs AMGN · MOH vs CDNA · MOH vs DGX